Table 4.
AnalysisofjointinfluenceofgenotypesathOGG1rs1052133 and hMUTYH rs3219472 on risk of nasopharyngeal carcinoma
Genotype
|
NPC | Control | P* | Adjusted ORa (95% CI) | |
---|---|---|---|---|---|
rs1052133 | rs3219472 | ||||
CC | AA | 13 | 6 | 1.00 | 1.00 |
GG | GG | 62 | 83 | 0.043 | 2.887 (1.033–8.072) |
GG | GA | 70 | 101 | 0.026 | 3.183 (1.147–8.835) |
GG | AA | 19 | 27 | 0.040 | 3.392 (1.059–10.870) |
CC | GG | 34 | 37 | 0.111 | NS |
CC | GA | 34 | 42 | 0.065 NS | NS |
CG | GG | 119 | 126 | 0.096 NS | NS |
CG | AA | 31 | 39 | 0.062 NS | NS |
CG | GA | 106 | 112 | 0.098 NS | NS |
Total | 488 | 573 |
Notes:
Calculated by multiple logistic regression after controlling for age, sex, and smoking history.
Calculated using the chi-squared test with respect to the P-value associated with the combination of genotype CC at hOGG1 rs1052133 and genotype AA at hMUTYH rs3219472. NS means not shown due to P>0.05.
Abbreviations: hOGG1, human 8-oxoguanine DNA glycosylase 1; hMUTYH, human MutY glycosylase homologue; NPC, nasopharyngeal carcinoma; OR, odds ratio; CI, confidence interval.